{"transactions":[{"id":1848071,"issuer":{"id":77243,"kind":"organization","name":"Elevation Oncology, Inc.","symbol":"ELEV"},"owners":[{"id":112071,"kind":"organization","name":"Aisling Capital IV, LP","position":1,"cik":"0001652910","reported_name":"Aisling Capital IV, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112072,"kind":"organization","name":"Aisling Capital Partners IV LLC","position":2,"cik":"0001737019","reported_name":"Aisling Capital Partners IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112073,"kind":"organization","name":"Aisling Capital Partners IV, LP","position":3,"cik":"0001737020","reported_name":"Aisling Capital Partners IV, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":61997,"kind":"person","name":"ELMS STEVE","position":4,"cik":"0001250195","reported_name":"ELMS STEVE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38918,"kind":"person","name":"SCHIFF ANDREW N","position":5,"cik":"0001172252","reported_name":"SCHIFF ANDREW N","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-21T16:09:11.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":31238,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 100% of the total shares on the one-year anniversary of the grant date, subject to the Reporting Person's provision of service to the Issuer on such vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This stock option was granted to Steven Elms, an employee of Aisling Capital, in his capacity as a director of the Issuer. Pursuant to the policies of Aisling Capital, Mr. Elms does not have any right to any of the Issuer's securities issued as part of his service on the Board and Aisling Capital is entitled to receive all of the pecuniary interest in the securities issued."}],"balance_after":31238,"derivative":{"exercise_price":1.47,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":31238},"source":{"system":"sec-edgar","filing":"0001415889-23-010090","document":"form4-06212023_080601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1172252/000141588923010090/form4-06212023_080601.xml","form_type":"4"}},{"id":2224424,"issuer":{"id":77243,"kind":"organization","name":"Elevation Oncology, Inc.","symbol":"ELEV"},"owners":[{"id":112071,"kind":"organization","name":"Aisling Capital IV, LP","position":1,"cik":"0001652910","reported_name":"Aisling Capital IV, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112072,"kind":"organization","name":"Aisling Capital Partners IV LLC","position":2,"cik":"0001737019","reported_name":"Aisling Capital Partners IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112073,"kind":"organization","name":"Aisling Capital Partners IV, LP","position":3,"cik":"0001737020","reported_name":"Aisling Capital Partners IV, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":61997,"kind":"person","name":"ELMS STEVE","position":4,"cik":"0001250195","reported_name":"ELMS STEVE","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38918,"kind":"person","name":"SCHIFF ANDREW N","position":5,"cik":"0001172252","reported_name":"SCHIFF ANDREW N","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-22T18:43:39.000Z","date":"2022-06-17","kind":"grant","acquired":true,"shares":15619,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 100% of the total shares on the one year anniversary of the grant date, subject to the Reporting Person's provision of service to the Issuer on such vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This stock option was granted to Steven Elms, an employee of Aisling Capital, in his capacity as a director of the Issuer. Pursuant to the policies of Aisling Capital, Mr. Elms does not have any right to any of the Issuer's securities issued as part of his service on the Board and Aisling Capital is entitled to receive all of the pecuniary interest in the securities issued."}],"balance_after":15619,"derivative":{"exercise_price":1.31,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":15619},"source":{"system":"sec-edgar","filing":"0001209191-22-038760","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1172252/000120919122038760/doc4.xml","form_type":"4"}},{"id":2648146,"issuer":{"id":77243,"kind":"organization","name":"Elevation Oncology, Inc.","symbol":"ELEV"},"owners":[{"id":112071,"kind":"organization","name":"Aisling Capital IV, LP","position":1,"cik":"0001652910","reported_name":"Aisling Capital IV, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112072,"kind":"organization","name":"Aisling Capital Partners IV LLC","position":2,"cik":"0001737019","reported_name":"Aisling Capital Partners IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112073,"kind":"organization","name":"Aisling Capital Partners IV, LP","position":3,"cik":"0001737020","reported_name":"Aisling Capital Partners IV, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":61997,"kind":"person","name":"ELMS STEVE","position":4,"cik":"0001250195","reported_name":"ELMS STEVE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member"}},{"id":38918,"kind":"person","name":"SCHIFF ANDREW N","position":5,"cik":"0001172252","reported_name":"SCHIFF ANDREW N","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member"}}],"security":"Series B Preferred Stock","published_at":"2021-07-01T18:29:04.000Z","date":"2021-06-29","kind":"exercise","acquired":false,"shares":1936834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Shares of the Issuer's Preferred Stock automatically converted on a 4.225582-for-one basis into the number of shares of the Issuer's Common Stock in shown in column 7 immediately upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Shares of the Issuer's Preferred Stock automatically converted on a 4.225582-for-one basis into the number of shares of the Issuer's Common Stock in shown in column 7 immediately upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Shares of the Issuer's Preferred Stock automatically converted on a 4.225582-for-one basis into the number of shares of the Issuer's Common Stock in shown in column 7 immediately upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are directly held by Aisling Capital IV, LP (\"Aisling\").  Aisling Capital Partners IV, LP (\"Aisling GP\"), is the general partner of Aisling, and Aisling Capital Partners IV LLC (\"Aisling Partners\"), is the general partner of Aisling GP. The managers of Aisling Partners are Dr. Andrew Schiff and Steve Elms and may share voting power and dispositive powers over securities held by Aisling, and as a result, may be deemed to have beneficial ownership over such securities. Each of the reporting persons disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":458360},"source":{"system":"sec-edgar","filing":"0001209191-21-044561","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1172252/000120919121044561/doc4.xml","form_type":"4"}},{"id":2648145,"issuer":{"id":77243,"kind":"organization","name":"Elevation Oncology, Inc.","symbol":"ELEV"},"owners":[{"id":112071,"kind":"organization","name":"Aisling Capital IV, LP","position":1,"cik":"0001652910","reported_name":"Aisling Capital IV, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112072,"kind":"organization","name":"Aisling Capital Partners IV LLC","position":2,"cik":"0001737019","reported_name":"Aisling Capital Partners IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112073,"kind":"organization","name":"Aisling Capital Partners IV, LP","position":3,"cik":"0001737020","reported_name":"Aisling Capital Partners IV, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":61997,"kind":"person","name":"ELMS STEVE","position":4,"cik":"0001250195","reported_name":"ELMS STEVE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member"}},{"id":38918,"kind":"person","name":"SCHIFF ANDREW N","position":5,"cik":"0001172252","reported_name":"SCHIFF ANDREW N","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member"}}],"security":"Series A Preferred Stock","published_at":"2021-07-01T18:29:04.000Z","date":"2021-06-29","kind":"exercise","acquired":false,"shares":8000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Shares of the Issuer's Preferred Stock automatically converted on a 4.225582-for-one basis into the number of shares of the Issuer's Common Stock in shown in column 7 immediately upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Shares of the Issuer's Preferred Stock automatically converted on a 4.225582-for-one basis into the number of shares of the Issuer's Common Stock in shown in column 7 immediately upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Shares of the Issuer's Preferred Stock automatically converted on a 4.225582-for-one basis into the number of shares of the Issuer's Common Stock in shown in column 7 immediately upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are directly held by Aisling Capital IV, LP (\"Aisling\").  Aisling Capital Partners IV, LP (\"Aisling GP\"), is the general partner of Aisling, and Aisling Capital Partners IV LLC (\"Aisling Partners\"), is the general partner of Aisling GP. The managers of Aisling Partners are Dr. Andrew Schiff and Steve Elms and may share voting power and dispositive powers over securities held by Aisling, and as a result, may be deemed to have beneficial ownership over such securities. Each of the reporting persons disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1893232},"source":{"system":"sec-edgar","filing":"0001209191-21-044561","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1172252/000120919121044561/doc4.xml","form_type":"4"}},{"id":2648144,"issuer":{"id":77243,"kind":"organization","name":"Elevation Oncology, Inc.","symbol":"ELEV"},"owners":[{"id":112071,"kind":"organization","name":"Aisling Capital IV, LP","position":1,"cik":"0001652910","reported_name":"Aisling Capital IV, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112072,"kind":"organization","name":"Aisling Capital Partners IV LLC","position":2,"cik":"0001737019","reported_name":"Aisling Capital Partners IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112073,"kind":"organization","name":"Aisling Capital Partners IV, LP","position":3,"cik":"0001737020","reported_name":"Aisling Capital Partners IV, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":61997,"kind":"person","name":"ELMS STEVE","position":4,"cik":"0001250195","reported_name":"ELMS STEVE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member"}},{"id":38918,"kind":"person","name":"SCHIFF ANDREW N","position":5,"cik":"0001172252","reported_name":"SCHIFF ANDREW N","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member"}}],"security":"Common Stock","published_at":"2021-07-01T18:29:04.000Z","date":"2021-06-29","kind":"purchase","acquired":true,"shares":187500,"price":16,"value":3000000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are directly held by Aisling Capital IV, LP (\"Aisling\").  Aisling Capital Partners IV, LP (\"Aisling GP\"), is the general partner of Aisling, and Aisling Capital Partners IV LLC (\"Aisling Partners\"), is the general partner of Aisling GP. The managers of Aisling Partners are Dr. Andrew Schiff and Steve Elms and may share voting power and dispositive powers over securities held by Aisling, and as a result, may be deemed to have beneficial ownership over such securities. Each of the reporting persons disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":2834910,"source":{"system":"sec-edgar","filing":"0001209191-21-044561","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1172252/000120919121044561/doc4.xml","form_type":"4"}},{"id":2648143,"issuer":{"id":77243,"kind":"organization","name":"Elevation Oncology, Inc.","symbol":"ELEV"},"owners":[{"id":112071,"kind":"organization","name":"Aisling Capital IV, LP","position":1,"cik":"0001652910","reported_name":"Aisling Capital IV, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112072,"kind":"organization","name":"Aisling Capital Partners IV LLC","position":2,"cik":"0001737019","reported_name":"Aisling Capital Partners IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112073,"kind":"organization","name":"Aisling Capital Partners IV, LP","position":3,"cik":"0001737020","reported_name":"Aisling Capital Partners IV, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":61997,"kind":"person","name":"ELMS STEVE","position":4,"cik":"0001250195","reported_name":"ELMS STEVE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member"}},{"id":38918,"kind":"person","name":"SCHIFF ANDREW N","position":5,"cik":"0001172252","reported_name":"SCHIFF ANDREW N","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member"}}],"security":"Common Stock","published_at":"2021-07-01T18:29:04.000Z","date":"2021-06-29","kind":"exercise","acquired":true,"shares":458360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Shares of the Issuer's Preferred Stock automatically converted on a 4.225582-for-one basis into the number of shares of the Issuer's Common Stock in shown in column 7 immediately upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are directly held by Aisling Capital IV, LP (\"Aisling\").  Aisling Capital Partners IV, LP (\"Aisling GP\"), is the general partner of Aisling, and Aisling Capital Partners IV LLC (\"Aisling Partners\"), is the general partner of Aisling GP. The managers of Aisling Partners are Dr. Andrew Schiff and Steve Elms and may share voting power and dispositive powers over securities held by Aisling, and as a result, may be deemed to have beneficial ownership over such securities. Each of the reporting persons disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":2647410,"source":{"system":"sec-edgar","filing":"0001209191-21-044561","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1172252/000120919121044561/doc4.xml","form_type":"4"}},{"id":2648142,"issuer":{"id":77243,"kind":"organization","name":"Elevation Oncology, Inc.","symbol":"ELEV"},"owners":[{"id":112071,"kind":"organization","name":"Aisling Capital IV, LP","position":1,"cik":"0001652910","reported_name":"Aisling Capital IV, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112072,"kind":"organization","name":"Aisling Capital Partners IV LLC","position":2,"cik":"0001737019","reported_name":"Aisling Capital Partners IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112073,"kind":"organization","name":"Aisling Capital Partners IV, LP","position":3,"cik":"0001737020","reported_name":"Aisling Capital Partners IV, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":61997,"kind":"person","name":"ELMS STEVE","position":4,"cik":"0001250195","reported_name":"ELMS STEVE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member"}},{"id":38918,"kind":"person","name":"SCHIFF ANDREW N","position":5,"cik":"0001172252","reported_name":"SCHIFF ANDREW N","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member"}}],"security":"Common Stock","published_at":"2021-07-01T18:29:04.000Z","date":"2021-06-29","kind":"exercise","acquired":true,"shares":1893232,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Shares of the Issuer's Preferred Stock automatically converted on a 4.225582-for-one basis into the number of shares of the Issuer's Common Stock in shown in column 7 immediately upon the closing of the Issuer's initial public offering, and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are directly held by Aisling Capital IV, LP (\"Aisling\").  Aisling Capital Partners IV, LP (\"Aisling GP\"), is the general partner of Aisling, and Aisling Capital Partners IV LLC (\"Aisling Partners\"), is the general partner of Aisling GP. The managers of Aisling Partners are Dr. Andrew Schiff and Steve Elms and may share voting power and dispositive powers over securities held by Aisling, and as a result, may be deemed to have beneficial ownership over such securities. Each of the reporting persons disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein."}],"balance_after":2189050,"source":{"system":"sec-edgar","filing":"0001209191-21-044561","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1172252/000120919121044561/doc4.xml","form_type":"4"}},{"id":2653846,"issuer":{"id":77243,"kind":"organization","name":"Elevation Oncology, Inc.","symbol":"ELEV"},"owners":[{"id":112071,"kind":"organization","name":"Aisling Capital IV, LP","position":1,"cik":"0001652910","reported_name":"Aisling Capital IV, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112072,"kind":"organization","name":"Aisling Capital Partners IV LLC","position":2,"cik":"0001737019","reported_name":"Aisling Capital Partners IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112073,"kind":"organization","name":"Aisling Capital Partners IV, LP","position":3,"cik":"0001737020","reported_name":"Aisling Capital Partners IV, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":61997,"kind":"person","name":"ELMS STEVE","position":4,"cik":"0001250195","reported_name":"ELMS STEVE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member"}},{"id":38918,"kind":"person","name":"SCHIFF ANDREW N","position":5,"cik":"0001172252","reported_name":"SCHIFF ANDREW N","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Managing Member"}}],"security":"Director Stock Option","published_at":"2021-06-28T18:18:35.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":31238,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was granted to Steven Elms, an employee of Aisling Capital, in his capacity as a director of the Issuer. Pursuant to the policies of Aisling Capital, Mr. Elms does not have any right to any of the Issuer's securities issued as part of his service on the Board and Aisling Capital is entitled to receive all of the pecuniary interest in the securities issued. The stock option vests as of 1/36 of the total shares monthly beginning on July 24, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":31238,"derivative":{"exercise_price":16,"expiration_date":"2031-06-23","underlying":"Common Stock","underlying_shares":31238},"source":{"system":"sec-edgar","filing":"0001209191-21-043527","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1172252/000120919121043527/doc4.xml","form_type":"4"}},{"id":3349952,"issuer":{"id":12518,"kind":"organization","name":"Zosano Pharma Corp","symbol":"ZSAN"},"owners":[{"id":112071,"kind":"organization","name":"Aisling Capital IV, LP","position":1,"cik":"0001652910","reported_name":"Aisling Capital IV, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112073,"kind":"organization","name":"Aisling Capital Partners IV, LP","position":2,"cik":"0001737020","reported_name":"Aisling Capital Partners IV, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112072,"kind":"organization","name":"Aisling Capital Partners IV LLC","position":3,"cik":"0001737019","reported_name":"Aisling Capital Partners IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":61997,"kind":"person","name":"ELMS STEVE","position":4,"cik":"0001250195","reported_name":"ELMS STEVE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38918,"kind":"person","name":"SCHIFF ANDREW N","position":5,"cik":"0001172252","reported_name":"SCHIFF ANDREW N","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value of $0.0001","published_at":"2019-12-06T10:23:17.000Z","date":"2019-12-02","kind":"grant","acquired":true,"shares":689655,"price":1.45,"value":999999.75,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities are directly held by Aisling Capital IV, LP (\"Aisling\"), and may be deemed to be beneficially owned by Aisling Capital Partners IV, LP (\"Aisling GP\"), as general partner of Aisling, Aisling Capital Partners IV LLC (\"Aisling Partners\"), as general partner of Aisling GP, and each of the individual managing members and partners (collectively, the \"Managers\") of Aisling GP and Aisling Partners. The Managers of Aisling Partners are Dr. Andrew Schiff and Steve Elms."}],"balance_after":2718226,"source":{"system":"sec-edgar","filing":"0000899243-19-028646","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1172252/000089924319028646/doc4.xml","form_type":"4"}},{"id":3462033,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":112071,"kind":"organization","name":"Aisling Capital IV, LP","position":1,"cik":"0001652910","reported_name":"Aisling Capital IV, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112072,"kind":"organization","name":"Aisling Capital Partners IV LLC","position":2,"cik":"0001737019","reported_name":"Aisling Capital Partners IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112073,"kind":"organization","name":"Aisling Capital Partners IV, LP","position":3,"cik":"0001737020","reported_name":"Aisling Capital Partners IV, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38918,"kind":"person","name":"SCHIFF ANDREW N","position":4,"cik":"0001172252","reported_name":"SCHIFF ANDREW N","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":61997,"kind":"person","name":"ELMS STEVE","position":5,"cik":"0001250195","reported_name":"ELMS STEVE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-07-15T16:15:23.000Z","date":"2019-07-15","kind":"purchase","acquired":true,"shares":2500000,"price":0.6,"value":1500000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by Aisling Capital IV, LP (\"Aisling\"). Aisling Capital Partners IV, LP (\"Aisling GP\"), is the general partner of Aisling. Aisling Capital Partners IV LLC (\"Aisling Partners\"), is the general partner of Aisling GP. The individual managing members (\"the Aisling Managers\"), of Aisling Partners are Andrew Schiff, M.D. and Steve Elms. By virtue of these relationships, Aisling GP, Aisling Partners and the Aisling Managers may be deemed to have voting and investment power over the shares held by Aisling. Each of the reporting persons, other than Aisling, disclaims beneficial ownership of the shares held by Aisling, except to the extent of any pecuniary interest therein, if any."}],"balance_after":10100000,"source":{"system":"sec-edgar","filing":"0000899243-19-019602","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000089924319019602/doc4.xml","form_type":"4"}},{"id":3556782,"issuer":{"id":12518,"kind":"organization","name":"Zosano Pharma Corp","symbol":"ZSAN"},"owners":[{"id":112071,"kind":"organization","name":"Aisling Capital IV, LP","position":1,"cik":"0001652910","reported_name":"Aisling Capital IV, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112073,"kind":"organization","name":"Aisling Capital Partners IV, LP","position":2,"cik":"0001737020","reported_name":"Aisling Capital Partners IV, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":112072,"kind":"organization","name":"Aisling Capital Partners IV LLC","position":3,"cik":"0001737019","reported_name":"Aisling Capital Partners IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":61997,"kind":"person","name":"ELMS STEVE","position":4,"cik":"0001250195","reported_name":"ELMS STEVE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":38918,"kind":"person","name":"SCHIFF ANDREW N","position":5,"cik":"0001172252","reported_name":"SCHIFF ANDREW N","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value of $0.0001","published_at":"2019-04-12T16:15:56.000Z","date":"2019-04-11","kind":"grant","acquired":true,"shares":428571,"price":3.5,"value":1499998.5,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities are directly held by Aisling Capital IV, LP (\"Aisling\"), and may be deemed to be beneficially owned by Aisling Capital Partners IV, LP (\"Aisling GP\"), as general partner of Aisling, Aisling Capital Partners IV LLC (\"Aisling Partners\"), as general partner of Aisling GP, and each of the individual managing members and partners (collectively, the \"Managers\") of Aisling GP and Aisling Partners. The Managers of Aisling Partners are Dr. Andrew Schiff and Steve Elms."}],"balance_after":2028571,"source":{"system":"sec-edgar","filing":"0000899243-19-010594","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1172252/000089924319010594/doc4.xml","form_type":"4"}}]}